BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38009614)

  • 21. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
    Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
    Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.
    Leitz J; Reuschenbach M; Lohrey C; Honegger A; Accardi R; Tommasino M; Llano M; von Knebel Doeberitz M; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS Pathog; 2014 Mar; 10(3):e1003957. PubMed ID: 24604027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
    Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
    Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
    Li Y; Patterson MR; Morgan EL; Wasson CW; Ryder EL; Barba-Moreno D; Scarth JA; Wang M; Macdonald A
    J Med Virol; 2023 Aug; 95(8):e29025. PubMed ID: 37565725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.
    Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL
    Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
    Shukla S; Mahata S; Shishodia G; Pandey A; Tyagi A; Vishnoi K; Basir SF; Das BC; Bharti AC
    PLoS One; 2013; 8(7):e67849. PubMed ID: 23874455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dickkopf-1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV-positive cancer cells in a JNK-dependent manner.
    Frensemeier K; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2022 Dec; 151(12):2215-2228. PubMed ID: 36094276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
    Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
    Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
    Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
    Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
    Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
    Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling.
    Khan SF; Burmeister CA; Scott DJ; Sinkala M; Ramburan A; Wu HT; Schäfer G; Katz AA; Prince S
    Mol Cancer Res; 2023 Apr; 21(4):345-358. PubMed ID: 36622795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
    Li F; Cui J
    Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
    Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.